The aggregation of
the amyloid β (Aβ) peptide is one
of the molecular hallmarks of Alzheimer’s disease (AD). Although
Aβ deposits have mostly been observed extracellularly, various
studies have also reported the presence of intracellular Aβ
assemblies. Because these intracellular Aβ aggregates might
play a role in the onset and progression of AD, it is important to
investigate their possible origins at different locations of the cell
along the secretory pathway of the amyloid precursor protein, from
which Aβ is derived by proteolytic cleavage. Senile plaques
found in AD are largely composed of the 42-residue form of Aβ
(Aβ42). Intracellularly, Aβ42 is
produced in the endoplasmatic reticulum (ER) and Golgi apparatus.
Since lipid bilayers have been shown to promote the aggregation of
Aβ, in this study, we measure the effects of the lipid membrane
composition on the in vitro aggregation kinetics of Aβ42. By using large unilamellar vesicles to model cellular membranes
at different locations, including the inner and outer leaflets of
the plasma membrane, late endosomes, the ER, and the Golgi apparatus,
we show that Aβ42 aggregation is inhibited by the
ER and Golgi model membranes. These results provide a preliminary
map of the possible effects of the membrane composition in different
cellular locations on Aβ aggregation and suggest the presence
of an evolutionary optimization of the lipid composition to prevent
the intracellular aggregation of Aβ.